Cellular senescence is associated with osteonecrosis of the femoral head while mesenchymal stem cell conditioned medium inhibits bone collapse

• Published in: Scientific reports Vol. 14; no. 1; p. 3329
• Main Authors: Okamoto, Masanori, Nakashima, Hiroaki, Sakai, Kiyoshi, Takegami, Yasuhiko, Osawa, Yusuke, Watanabe, Junna, Ito, Sadayuki, Hibi, Hideharu, Imagama, Shiro
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 09.02.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/532/2074; 631/80/509; 631/80/82; 692/699/1670/407; Bone growth; Bone surgery; Cancellous bone; Femur; Humanities and Social Sciences; INK4a protein; Ischemia; Mesenchymal stem cells; multidisciplinary; Necrosis; Nestin; Osteogenesis; Osteonecrosis; p16 Protein; p53 Protein; Science; Science (multidisciplinary); Senescence; Stem cells; β-Galactosidase
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-53400-w

Osteonecrosis of the femoral head (ONFH) is a type of ischemic osteonecrosis that causes pain, loss of function, and femoral head collapse. Here, we analyzed samples of femoral heads excised from patients with ONFH to clarify the relationship between ischemic osteonecrosis and cellular senescence. X-gal staining was strong and p16INK4a-positive cells were abundant in the transitional region of ONFH. The β-galactosidase-positive cells in the transitional region were also positive for nestin, periostin, or DMP-1. In contrast, no β-galactosidase-positive cells were detected in the healthy region. The senescence-associated p16INK4a, p21, and p53 were upregulated in ONFH tissue. We also examined and analyzed a mouse ischemic femoral osteonecrosis model in vivo to verify the association between ONFH and cellular senescence. Human mesenchymal stem cell-conditioned medium (MSC-CM) was administered to determine its therapeutic efficacy against cellular senescence and bone collapse. MSC-CM reduced the number of senescent cells and downregulated the aforementioned senescence-related genes. It also decreased the number of empty lacunae 4 weeks after ischemia induction and promoted bone formation. At 6 weeks post-surgery, MSC-CM increased the trabecular bone volume, thereby suppressing bone collapse. We conclude that cellular senescence is associated with ONFH and that MSC-CM suppresses bone collapse in this disorder.